Park Ha Biological Technology is trading 10.11% lower at $2.49 on September 28, 2026, with no clear company-specific catalyst identified.
- A securities class-action lead-plaintiff deadline falls on September 28, but available reporting does not link it to the decline.
- Broader markets are also lower amid rising oil prices and rate concerns; supplied index moves are below 0.5%, and a market-wide explanation for this larger decline is unconfirmed.